Cargando…

BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury

Detalles Bibliográficos
Autores principales: Marola, Olivia J., Yablonski, Sarah E. R., Shrager, Peter G., Nickells, Robert W., Libby, Richard T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307748/
https://www.ncbi.nlm.nih.gov/pubmed/35869049
http://dx.doi.org/10.1038/s41420-022-01111-4
_version_ 1784752833090813952
author Marola, Olivia J.
Yablonski, Sarah E. R.
Shrager, Peter G.
Nickells, Robert W.
Libby, Richard T.
author_facet Marola, Olivia J.
Yablonski, Sarah E. R.
Shrager, Peter G.
Nickells, Robert W.
Libby, Richard T.
author_sort Marola, Olivia J.
collection PubMed
description
format Online
Article
Text
id pubmed-9307748
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93077482022-07-24 BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury Marola, Olivia J. Yablonski, Sarah E. R. Shrager, Peter G. Nickells, Robert W. Libby, Richard T. Cell Death Discov Comment Nature Publishing Group UK 2022-07-22 /pmc/articles/PMC9307748/ /pubmed/35869049 http://dx.doi.org/10.1038/s41420-022-01111-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Comment
Marola, Olivia J.
Yablonski, Sarah E. R.
Shrager, Peter G.
Nickells, Robert W.
Libby, Richard T.
BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
title BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
title_full BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
title_fullStr BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
title_full_unstemmed BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
title_short BclX(L) (Bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
title_sort bclx(l) (bcl2l1) gene therapy lessens retinal ganglion cell soma loss but not axonal degeneration after acute axonal injury
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307748/
https://www.ncbi.nlm.nih.gov/pubmed/35869049
http://dx.doi.org/10.1038/s41420-022-01111-4
work_keys_str_mv AT marolaoliviaj bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury
AT yablonskisaraher bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury
AT shragerpeterg bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury
AT nickellsrobertw bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury
AT libbyrichardt bclxlbcl2l1genetherapylessensretinalganglioncellsomalossbutnotaxonaldegenerationafteracuteaxonalinjury